查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104604

胚胎胚胎著床前基因檢測市場：按產品、應用、最終用戶、技術、國家和地區分類－產業分析、市場規模、市場佔有率和預測（2026-2033 年）

Preimplantation Genetic Testing Market, By Product, By Application, By End User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 399 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，胚胎著床前遺傳學檢測 (PGD) 市值將達到 8.304 億美元，並將在 2026 年至 2033 年期間以 9.8% 的複合年成長率成長。

胚胎胚胎著床前遺傳學檢測（PGT）市場涵蓋利用基因檢測技術篩檢胚胎著床前（IVF）產生的胚胎，並檢測染色體異常、遺傳疾病和染色體重排。 PGT能夠從遺傳學角度篩選出健康的胚胎，從而提高IVF的成功率，同時最大限度地降低遺傳疾病的傳播風險和流產風險。

由於遺傳疾病發生率上升、不孕症發病率增加、女性老化以及輔助生殖技術（ART）的廣泛應用，胚胎植入前遺傳學檢測市場正經歷快速成長。次世代定序（NGS）、聚合酵素鏈鎖反應（PCR）和微陣列技術的進步有助於提高胚胎篩檢的有效性。此外，人們對生殖遺傳學的認知不斷提高、政府對不孕症治療的支持以及對精準醫療的投資，預計都將進一步推動全球胚胎著床前遺傳學檢測市場的成長。

胚胎著床前基因檢測市場 - 市場動態

輔助生殖技術的日益普及推動了胚胎著床前基因檢測市場的成長。

輔助生殖技術（ART）的日益普及是推動胚胎植入前遺傳學檢測（PGT）市場成長的主要因素之一。隨著出生率的上升、生活方式的改變、肥胖症的流行以及生殖系統疾病導致的不孕症發病率的增加，越來越多的夫婦選擇透過體外受精（IVF）進行治療。 PGT 能夠在胚胎移植前識別染色體異常、單基因疾病和染色體結構重排，因此已成為 IVF 的重要組成部分。這有助於最佳化胚胎選擇、提高著床率、降低自然流產的風險，並減少遺傳疾病傳給後代的風險。

根據歐洲人類生殖與胚胎學會（ESHRE）的數據，歐洲每年進行超過一百萬個輔助生殖技術（ART）治療週期，顯示ART的普及率不斷提高，對先進的胚胎遺傳篩檢的需求也日益成長。此外，次世代定序（NGS）和PCR技術的不斷進步正在提高胚胎植入前遺傳學檢測（PGT）的準確性和速度。同時，人們對生殖遺傳學的認知不斷提高、生育診所的擴張以及一些國家有利的監管政策也促進了PGT服務的使用。體外受精（IVF）週期的增加以及對個人化生殖醫療服務需求的成長預計將在未來幾年推動胚胎著床前遺傳學檢測市場的發展。

胚胎著床前基因檢測市場—細分分析：

全球胚胎著床前基因檢測市場按產品、應用、最終用戶、技術和地區進行細分。

在胚胎著床前遺傳學檢測（PGD）市場中，胚胎著床前遺傳學檢測（PGT-A）佔據最大的市場佔有率，該檢測廣泛應用於體外受精（IVF）治療中，用於檢測染色體異常。這種基因檢測可以提高胚胎著床率，降低流產風險，並提高懷孕成功率，尤其對高齡女性而言。此外，次世代定序技術的日益普及正在提升PGT-A檢測服務的效率和準確性。例如，2026年5月，GenEmbryomics Limited公司發布了XGEN PGT-X™，這是全球胚胎著床前用於IVF胚胎的臨床級全基因組PGD解決方案。該方案透過公司的早期准入合作夥伴計畫提供，旨在提供價格合理且全面的胚胎基因測序。此外，隨著胚胎胚胎著床前遺傳疾病篩檢基因檢測的日益普及，PGT-M（單基因疾病胚胎胚胎著床前遺傳學檢測）檢測服務預計未來將迎來高速成長。

按應用領域分類，「體外受精胚胎選擇」佔據最大的市場佔有率，這主要得益於全球體外受精手術數量的不斷成長以及人們對提高懷孕成功率日益成長的關注。此外，隨著生殖遺傳學在生育治療中日益普及，「遺傳疾病篩檢」、「預防復發性流產」和「高級生育規劃」的應用也不斷增加。按終端用戶分類，生育診所憑藉其專業的體外受精實驗室、先進的切片檢查技術和綜合基因檢測服務，在市場中佔據主導地位。按技術分類，次世代定序（NGS）憑藉其高精度、擴充性以及能夠同時檢測染色體異常和基因突變的能力，佔據最大的市場佔有率，使其成為現代胚胎著床前遺傳學檢測的首選技術。

胚胎著床前基因檢測市場—區域分析

北美在胚胎著床前遺傳學檢測（PGT）市場佔最大佔有率。這主要歸功於該地區輔助生殖技術（ART）的高普及率、先進的基因檢測設施以及許多知名生育診所和生殖遺傳實驗室的存在。此外，對遺傳疾病的深入了解、母親年齡的成長以及基於次世代定序（NGS）的胚胎篩檢在體外受精（IVF）中的日益普及，也是推動市場擴張的因素。根據美國疾病管制與預防中心（CDC）的數據顯示，由於對IVF治療的持續需求，美國每年進行的ART手術數量龐大。 CDC的國家ART監測系統（NASS）每年從全美約500家生育診所收集數據。根據該系統的數據，2022 年大約進行了 435,426 個 ART 週期。隨著 ART 手術數量的增加，PGT 的使用也隨之擴大，這使得北美成為全球市場的主導地區。

歐洲也是一個重要的市場，這得益於其完善的生育治療網路、許多國家良好的法規環境以及生殖遺傳學技術的持續發展。尤其是在西班牙、英國、義大利和丹麥等國家，體外受精（IVF）和胚胎篩檢治療的使用率不斷提高。歐洲每年進行超過一百萬個輔助生殖技術（ART）治療週期，顯示對IVF治療和包括PGT-A、PGT-M和PGT-SR在內的先進基因檢測的需求日益成長。預計生育診所對次世代定序（NGS）檢測的日益普及將進一步推動該地區的市場成長。

目錄

第1章：胚胎著床前基因檢測市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：胚胎著床前的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：胚胎著床前基因檢測產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：胚胎著床前基因檢測市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：胚胎著床前基因檢測的市場趨勢

  • 2025年胚胎著床前基因檢測市佔分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章胚胎著床前基因檢測市場：依產品分類

  • 概述
    • 基於細分市場的市佔率分析：按產品
    • PGT-A 測試服務
    • PGT-M 檢測服務
    • PGT-SR 測試服務
    • 其他

第8章胚胎著床前基因檢測市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 體外受精（IVF）中的胚胎選擇
    • 遺傳疾病篩檢
    • 預防復發性流產
    • 高級不孕症治療方案
    • 其他

第9章胚胎著床前基因檢測市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 不孕症治療診所
    • 醫院
    • 診斷檢查室
    • 研究機構

第10章：胚胎著床前基因檢測市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 次世代定序
    • 聚合酵素鏈鎖反應（PCR）
    • 螢光原位雜合反應（FISH）
    • 微陣列技術
    • 其他

第11章胚胎著床前基因檢測市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：胚胎著床前基因檢測產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Vitrolife Group（Igenomix）
    • CooperGenomics（CooperSurgical）
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Natera, Inc.
    • Laboratory Corporation of America Holdings（Labcorp）
    • Eurofins Scientific
    • Quest Diagnostics Incorporated
    • Agilent Technologies, Inc.
    • Revvity, Inc.
    • BGI Genomics Co., Ltd.
    • Genea Biomedx
    • GeneDx
    • SOPHiA GENETICS
    • FUJIFILM Irvine Scientific
    • Oxford Gene Technology（Sysmex）
    • Pacific Biosciences（PacBio）
    • Merck KGaA
    • Juno Genetics
    • Progenesis, Inc.
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7135

Preimplantation Genetic Testing Market size was valued at US$ 830.4 Million in 2025, expanding at a CAGR of 9.8% from 2026 to 2033.

The Preimplantation Genetic Testing (PGT) Market includes the use of technologies for genetic testing that help screen the embryos that are produced via in vitro fertilization (IVF) in order to detect chromosomal anomalies, inheritable genetic disorders, and chromosome rearrangement. Preimplantation Genetic Testing (PGT) allows selecting healthy embryos from a genetic standpoint, thus boosting the chances of IVF success while minimizing the risks of transmission of genetic disorders and fetal losses.

The market demonstrates rapid growth due to the growing incidence of genetic disorders, increasing infertility levels, growing age of women, and the adoption of ART procedures. The advances in next generation sequencing (NGS), polymerase chain reaction (PCR), and microarray technologies help boost the effectiveness of the embryo screening. Moreover, growing awareness of reproductive genetics, government support for fertility treatments, and investments in precision medicine should contribute to the further growth of the global Preimplantation Genetic Testing Market.

Preimplantation Genetic Testing Market- Market Dynamics

Rising Utilization of Assisted Reproductive Technologies Drives Preimplantation Genetic Testing Market Growth

The rising use of assisted reproductive technology (ART) forms one of the major factors contributing to the expansion of the PGT market. The growing incidence of infertility on account of delayed parenting, change in lifestyle choices, obesity, and reproductive diseases has resulted in more couples seeking treatment through in vitro fertilization (IVF). PGT has emerged as an important part of IVF through its ability to identify any chromosomal aberrations, single-gene disorders, and structural chromosome rearrangements prior to embryo transfer. It helps in improving embryo selection, enhances implantation rates, decreases the risk of spontaneous miscarriages, and reduces chances of transmitting hereditary diseases to offspring.

As per European Society of Human Reproduction and Embryology (ESHRE), more than 1 million ART treatment cycles are performed annually across Europe, highlighting the growing adoption of assisted reproductive technologies and the increasing need for advanced embryo genetic screening. Additionally, continuous developments in the fields of NGS and PCR technologies have resulted in enhanced precision and speed of PGT. Moreover, the awareness levels about reproductive genetics along with the expansion of fertility clinics and favorable regulations in certain nations are driving the uptake of PGT services. It is anticipated that the increase in the number of IVF cycles and the need for customized reproductive health services will drive the Preimplantation Genetic Testing Market over the coming years.

Preimplantation Genetic Testing Market- Segmentation Analysis:

The Global Preimplantation Genetic Testing Market is segmented on the basis of Product, Application, End User, Technology, and Region.

Based on Preimplantation Genetic Testing Market, By Test Type, Preimplantation Genetic Testing for Aneuploidy Testing Services held the largest market share on account of their extensive usage during IVF treatment process in order to detect any anomalies in chromosomes. Such a genetic test increases the chances of implantation, lowers risks of miscarriages, and increases chances of conception especially in case of older women. Moreover, increased use of next-generation sequencing technology has increased the efficiency and accuracy of PGT-A testing services. For example, in May 2026, GenEmbryomics Limited introduced XGEN PGT-X(TM), which is the world's first clinical grade whole genome preimplantation genetic testing solution used in IVF embryos. It was made available through the company's Early Access Partner Program in order to provide comprehensive embryo-genome sequencing at an affordable price. Furthermore, PGT-M (Preimplantation Genetic Testing for Monogenic Disorders) Testing Services will experience high growth in the future on account of growing number of genetic testings for the screening of inherited disorders prior to embryo implantation.

Based on Application, IVF Embryo Selection accounts for the largest market share owing to the increasing number of IVF procedures worldwide and the growing emphasis on improving pregnancy success rates. Genetic Disorder Screening, Recurrent Pregnancy Loss Prevention, and Advanced Fertility Planning are also witnessing increased adoption as reproductive genetics becomes more integrated into fertility care. Based on End User, Fertility Clinics dominate the market due to the availability of specialized IVF laboratories, advanced embryo biopsy capabilities, and integrated genetic testing services. Based on Technology, Next Generation Sequencing (NGS) holds the largest market share owing to its high accuracy, scalability, and ability to simultaneously detect chromosomal abnormalities and genetic mutations, making it the preferred technology for modern preimplantation genetic testing.

Preimplantation Genetic Testing Market- Geographical Insights

Regarding the Preimplantation Genetic Testing (PGT) Market, North America occupied the largest market share due to the high adoption rate of Assisted Reproductive Technologies (ART), advanced genetic testing facilities, and the presence of prominent fertility clinics and reproductive genetics laboratories in the region. Further contributing factors are an increased understanding of genetic disorders, increasing age of mothers, and the increasing adoption of next-generation sequencing (NGS) based embryo screening for in vitro fertilization (IVF). The Centers for Disease Control and Prevention (CDC) reports that the United States is consistently performing high number of ART procedures every year due to persistent demand for IVF treatment. The CDC's National ART Surveillance System (NASS) collects data every year from about 500 fertility clinics in the U.S. It reported that about 435,426 ART cycles were performed in 2022. An increase in the number of ART procedures performed has resulted in the increasing use of PGT as part of the process, thus making North America the leading region in the market globally.

Europe is another major market due to the existence of established networks for fertility treatments, supportive regulatory environments in many countries, and ongoing technological developments in reproductive genetics. There has been an increase in the number of cases where IVF and embryo screening treatments have been used, especially in countries such as Spain, UK, Italy, and Denmark. More than one million ART treatment cycles are performed annually in Europe each year, which demonstrates that there is increased demand for IVF treatment and advanced genetic testing, which include PGT-A, PGT-M, and PGT-SR. The increasing adoption of NGS testing in fertility clinics is likely to further boost market growth in the region.

Preimplantation Genetic Testing Market- Competitive Landscape:

The Competitive landscape of the Preimplantation Genetic Testing (PGT) Market consist of the presence of specialized reproductive genetics laboratories, molecular diagnostics firms, and ART solution providers who compete by virtue of innovation in technology, expansion of their labs, and collaborative efforts. The major players include Vitrolife Group (Igenomix), CooperGenomics, Thermo Fisher Scientific Inc., Illumina, Inc., Natera, Inc., Fulgent Genetics, Genea Biomedx, Invitae Corporation, Eurofins Scientific, and Laboratory Corporation of America Holdings (Labcorp). These firms are developing NGS-based preimplantation genetic testing products, automated workflows, and larger laboratories for improving the efficiency and speed of the process. Firms are also focusing on the expansion of global laboratory networks, collaborations with fertility clinics, and use of genomic technology in IVF. This is expected to increase competition in the global Preimplantation Genetic Testing Market.

Recent Developments:

In April 2024, GenEmbryomics Limited and Progenesis Inc. entered into a strategic partnership to expand access to advanced preimplantation genetic testing for IVF patients. The collaboration combined Progenesis' laboratory capabilities with GenEmbryomics' Panacea-GenomeScreen(TM) PGT-WGS technology, enabling comprehensive whole-genome embryo screening and advancing genetic testing solutions in reproductive medicine.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Vitrolife Group (Igenomix)
  • CooperGenomics (CooperSurgical)
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Labcorp)
  • Eurofins Scientific
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Revvity, Inc.
  • BGI Genomics Co., Ltd.
  • Genea Biomedx
  • GeneDx
  • SOPHiA GENETICS
  • FUJIFILM Irvine Scientific
  • Oxford Gene Technology (Sysmex)
  • Pacific Biosciences (PacBio)
  • Merck KGaA
  • Juno Genetics
  • Progenesis, Inc.
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • PGT-A Testing Services
  • PGT-M Testing Services
  • PGT-SR Testing Services
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • IVF Embryo Selection
  • Genetic Disorder Screening
  • Recurrent Pregnancy Loss Prevention
  • Advanced Fertility Planning
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Fertility Clinics
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In Situ Hybridization (FISH)
  • Microarray Technology
  • Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Preimplantation Genetic Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preimplantation Genetic Testing Market Snippet by Product
    • 2.1.2. Preimplantation Genetic Testing Market Snippet by Application
    • 2.1.3. Preimplantation Genetic Testing Market Snippet by End User
    • 2.1.4. Preimplantation Genetic Testing Market Snippet by Technology
    • 2.1.5. Preimplantation Genetic Testing Market Snippet by Country
    • 2.1.6. Preimplantation Genetic Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Preimplantation Genetic Testing Key Market Trends

  • 3.1. Preimplantation Genetic Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preimplantation Genetic Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preimplantation Genetic Testing Market Opportunities
  • 3.4. Preimplantation Genetic Testing Market Future Trends

4. Preimplantation Genetic Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preimplantation Genetic Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Preimplantation Genetic Testing Market Landscape

  • 6.1. Preimplantation Genetic Testing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preimplantation Genetic Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. PGT-A Testing Services
    • 7.1.3. PGT-M Testing Services
    • 7.1.4. PGT-SR Testing Services
    • 7.1.5. Others

8. Preimplantation Genetic Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. IVF Embryo Selection
    • 8.1.3. Genetic Disorder Screening
    • 8.1.4. Recurrent Pregnancy Loss Prevention
    • 8.1.5. Advanced Fertility Planning
    • 8.1.6. Others

9. Preimplantation Genetic Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Fertility Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Research Institutes

10. Preimplantation Genetic Testing Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Next Generation Sequencing
    • 10.1.3. Polymerase Chain Reaction (PCR)
    • 10.1.4. Fluorescence In Situ Hybridization (FISH)
    • 10.1.5. Microarray Technology
    • 10.1.6. Others

11. Preimplantation Genetic Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Preimplantation Genetic Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Preimplantation Genetic Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Preimplantation Genetic Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Preimplantation Genetic Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Preimplantation Genetic Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Preimplantation Genetic Testing Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Vitrolife Group (Igenomix)
    • 12.2.2. CooperGenomics (CooperSurgical)
    • 12.2.3. Thermo Fisher Scientific Inc.
    • 12.2.4. Illumina, Inc.
    • 12.2.5. Natera, Inc.
    • 12.2.6. Laboratory Corporation of America Holdings (Labcorp)
    • 12.2.7. Eurofins Scientific
    • 12.2.8. Quest Diagnostics Incorporated
    • 12.2.9. Agilent Technologies, Inc.
    • 12.2.10. Revvity, Inc.
    • 12.2.11. BGI Genomics Co., Ltd.
    • 12.2.12. Genea Biomedx
    • 12.2.13. GeneDx
    • 12.2.14. SOPHiA GENETICS
    • 12.2.15. FUJIFILM Irvine Scientific
    • 12.2.16. Oxford Gene Technology (Sysmex)
    • 12.2.17. Pacific Biosciences (PacBio)
    • 12.2.18. Merck KGaA
    • 12.2.19. Juno Genetics
    • 12.2.20. Progenesis, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us